Complement-mediated hemolysis persists year round in patients with cold agglutinin disease.

Alexander RöthJon FryzekXiaohui JiangHeidi ReichertParija PatelJun SuJaime Morales AriasCatherine M Broome

Published in: Transfusion (2021)

Patients with CAD had evidence of persistent chronic hemolysis, HRU, and thromboembolism risk year round.

Keyphrases